Protocol Involvement
- The START Follow-Up Study (CTN-0050)
- Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users (CTN-0049)
- Cocaine Use Reduction with Buprenorphine (CURB) (CTN-0048)
- Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes (CTN-0046)
- Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders (CTN-0044)
- Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement (CTN-0031)
- Prescription Opioid Addiction Treatment Study (POATS) (CTN-0030)
- Starting Treatment with Agonist Replacement Therapies (START) Study (CTN-0027)
- Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment (CTN-0019)
- Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment (CTN-0018)
- Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abusers (CTN-0014)
- Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs (CTN-0009)
- Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics (CTN-0007)
- Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics (CTN-0006)
- MET (Motivational Enhancement Treatment) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse (CTN-0004)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Outpatient Opiate Detoxification (CTN-0002)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Inpatient Opiate Detoxification (CTN-0001)
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
